SCHEMBL7154085

SCHEMBL7154085

CCOC(=O)N1CCC(Nc2[nH]c(N[C@H]3CC[C@H](N)CC3)nc3ncnc2-3)CC1.N[C@H]1CC[C@H](Nc2nc(Nc3cccc(C(=O)O)c3)c3nc[nH]c3n2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 8/20 0.38
MAPKAPK2 P49137 1/20 0.38
PRKCA P17252 1/20 0.38
CDK2 P24941 9/20 0.37
CCNE1 P24864 6/20 0.37
CCNE2 O96020 1/20 0.37
CCNA2 P20248 1/20 0.37
CCNA1 P78396 1/20 0.37
CDK4 P11802 3/20 0.37
CCND1 P24385 3/20 0.37
PDGFRA P16234 5/20 0.36
TTK P33981 1/20 0.36
MAP4K4 O95819 1/20 0.36
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895415 0.80 MAP4K4 (0.47) CDK1CDK2CCNA2CCNA1CDK4
SCHEMBL4895403 0.80 MAP4K4 (0.47) CDK1CDK2CCNA2CCNA1CDK4
SCHEMBL7110928 0.79 CSNK2A1 (0.47) CDK1PRKCACDK2CCNE1CCNE2
SCHEMBL7110933 0.79 CSNK2A1 (0.47) CDK1PRKCACDK2CCNE1CCNE2
SCHEMBL4889912 0.79 MAPKAPK2 (0.55) CDK1MAPKAPK2PRKCACDK2CCNE1
SCHEMBL4889926 0.79 MAPKAPK2 (0.55) CDK1MAPKAPK2PRKCACDK2CCNE1
SCHEMBL5891707 0.70 FLT3 (0.53) CDK1CDK2CCNE1PDGFRA
SCHEMBL5891718 0.70 FLT3 (0.53) CDK1CDK2CCNE1PDGFRA
Hydrochloric Acid SCHEMBL4892763 0.68 MAPKAPK2 (0.50) MAPKAPK2KDM4EALDH1A1LMNAMAPT
Hydrochloric Acid SCHEMBL4892770 0.68 MAPKAPK2 (0.50) MAPKAPK2KDM4EALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP disclosed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO disclosed